前列腺癌主动监测、放疗与根治性前列腺切除术后的患者报告结局指标与体验指标:前瞻性比较研究的系统综述
该系统综述纳入比较根治性前列腺切除术、放疗与主动监测治疗局限性前列腺癌的前瞻性临床试验,采用叙述性综合总结患者报告结局指标与体验指标。结果显示三种治疗对不同功能领域影响各异,对心理与生理生活质量均无显著影响,仅少数研究报告体验指标且各治疗方式决策后悔率最高达23%。
要点
- 根治性前列腺切除术主要影响控尿与性功能,但排尿症状结果优于其他治疗。
- 放疗与肠道功能和排尿症状的更大损害相关。
- 三种治疗对心理或生理生活质量均无显著影响,决策后悔率最高达23%。
核心结论
- 所有推荐的局限性前列腺癌治疗均对患者报告结局指标与体验指标有影响,但影响领域和严重程度不同。
- 患者报告结局指标收集存在显著异质性,需要在真实世界实践和临床试验中标准化。
- 仅少数研究报告患者报告体验指标,凸显未来研究应探索的未满足需求。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE和Cochrane CENTRAL数据库,遵循欧洲泌尿外科学会指南办公室建议和PRISMA声明。
- 纳入所有报告根治性前列腺切除术、放疗与主动监测比较的患者报告结局指标和/或体验指标的前瞻性临床试验。
- 采用叙述性综合总结研究结果,因研究异质性和局限性未进行定量合成。
主要发现
- 根治性前列腺切除术主要影响控尿和性功能,排尿症状结果优于其他治疗。
- 放疗与肠道功能和排尿症状的更大损害相关。
- 三种治疗对心理或生理生活质量均无显著影响。
- 仅少数研究报告患者报告体验指标,所有治疗方式的决策后悔率高达23%。
关键数值与推荐
- 决策后悔率在所有治疗方式中高达23%。
临床怎么用
- 研究结果可帮助医生和前列腺癌患者进行共享决策。
局限性
- 因现有研究的异质性和局限性,未进行定量合成。
- 患者报告结局指标收集存在显著异质性。
- 仅少数研究报告患者报告体验指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Current management options for localized prostate cancer (PCa) include radical prostatectomy (RP), radiotherapy (RT), and active surveillance (AS). Despite comparable oncological outcomes, there is still lack of evidence on their comparative effectiveness in terms of patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs). We conducted a systematic review of studies comparing PROMs and PREMs after all recommended management options for localized PCa (RP, RT, AS). METHODS: A literature search was performed in the MEDLINE, EMBASE, and Cochrane CENTRAL databases in accordance with recommendations from the European Association of Urology Guidelines Office and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. All prospective clinical trials reporting PROMs and/or PREMs for comparisons of RP versus RT versus AS were included. A narrative synthesis was used to summarize the review findings. No quantitative synthesis was performed because of the heterogeneity and limitations of the studies available. KEY FINDINGS AND LIMITATIONS: Our findings reveal that RP mostly affects urinary continence and sexual function, with better results for voiding symptoms in comparison to other treatments. RT was associated with greater impairment of bowel function and voiding symptoms. None of the treatments had a significant impact on mental or physical quality of life. Only a few studies reported PREMs, with a high rate of decision regret for all modalities (up to 23%). CONCLUSIONS AND CLINICAL IMPLICATIONS: All recommended treatments for localized PCa have an impact on PROMs and PREMs, but for different domains and with differing severity. We found significant heterogeneity in PROM collection, so standardization in real-world practice and clinical trials is warranted. Only a few studies have reported PREMs, highlighting an unmet need that should be explored in future studies. PATIENT SUMMARY: We reviewed differences in patient reports of their outcomes and experiences after surgical prostate removal, radiotherapy, or active surveillance for prostate cancer. We found differences in the effects on urinary, bowel, and sexual functions among the treatments, but no difference for mental or physical quality of life. Our results can help doctors and prostate cancer patients in shared decision-making.
引用
- Alberti A, Nicoletti R, Castellani D, et al. Patient-reported Outcome Measures and Experience Measures After Active Surveillance Versus Radiation Therapy Versus Radical Prostatectomy for Prostate Cancer: A Systematic Review of Prospective Comparative Studies. Eur Urol Oncol. 2024. PMID: 38816298. doi:10.1016/j.euo.2024.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。